By suppressing JNK and NF-ĸB downstream signaling with a JNK-In-8 JNK inhibitor, researchers have found that neuroinflammation is inhibited and neurological function is improved post-ischemic brain injury [41]. Here, MAPK8 is linked to brain injury.